• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估格雷夫斯眼病球后炎症的磁共振T2弛豫时间。

MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.

作者信息

Utech C I, Khatibnia U, Winter P F, Wulle K G

机构信息

University of Illinois College of Medicine at Peoria 61606, USA.

出版信息

Thyroid. 1995 Jun;5(3):185-93. doi: 10.1089/thy.1995.5.185.

DOI:10.1089/thy.1995.5.185
PMID:7580266
Abstract

The results of 39 patients with severe Graves' ophthalmopathy (GO), who were monitored by magnetic resonance imaging (MRI) and tonography before and after combined immunosuppressive treatment with cyclosporine and corticosteroids, are presented. A correlation was found between the decrease in T2 relaxation time of the superior, medial, and inferior rectus muscle (p < 0.01) and the response to the immunosuppressive treatment. Muscle thickness and intraocular pressure showed less improvement (p < 0.05). The infiltrative eye signs improved partially in correlation with the T2 relaxation time. By distinguishing inflammation of the extraorbital muscles from fibrosis, the T2 relaxation time can help to select patients that benefit from immunosuppressive treatment as well as to monitor the therapeutic effect.

摘要

本文呈现了39例重度格雷夫斯眼病(GO)患者在接受环孢素和皮质类固醇联合免疫抑制治疗前后,通过磁共振成像(MRI)和眼压描记法进行监测的结果。上直肌、内直肌和下直肌的T2弛豫时间缩短(p < 0.01)与免疫抑制治疗反应之间存在相关性。肌肉厚度和眼压改善程度较小(p < 0.05)。浸润性眼部体征与T2弛豫时间相关,部分得到改善。通过区分眶外肌炎症和纤维化,T2弛豫时间有助于选择能从免疫抑制治疗中获益的患者,并监测治疗效果。

相似文献

1
MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.用于评估格雷夫斯眼病球后炎症的磁共振T2弛豫时间。
Thyroid. 1995 Jun;5(3):185-93. doi: 10.1089/thy.1995.5.185.
2
Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.格雷夫斯眼病中的眼外肌:T2弛豫时间测量的作用
Radiology. 1994 Mar;190(3):857-62. doi: 10.1148/radiology.190.3.8115640.
3
Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.格雷夫斯眼病:复视患者的眼肌受累情况
Eur J Endocrinol. 2000 Jun;142(6):591-7. doi: 10.1530/eje.0.1420591.
4
[MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].[在内分泌性眼眶病中使用和不使用选择性脂肪抑制(SPIR)进行磁共振弛豫时间测量]
Rofo. 1997 Dec;167(6):557-64. doi: 10.1055/s-2007-1015583.
5
The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.定量眼眶磁共振成像在格雷夫斯眼病中的应用价值。
Clin Endocrinol (Oxf). 2001 Feb;54(2):205-9. doi: 10.1046/j.1365-2265.2001.01220.x.
6
[The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation].
Rofo. 1992 Sep;157(3):210-4. doi: 10.1055/s-2008-1033001.
7
Graves ophthalmopathy: MR imaging of the orbits.格雷夫斯眼病:眼眶的磁共振成像
Radiology. 1989 Sep;172(3):759-62. doi: 10.1148/radiology.172.3.2772184.
8
[Results of nuclear magnetic resonance tomography studies in endocrine orbitopathy].[内分泌性眼眶病的核磁共振断层扫描研究结果]
Klin Monbl Augenheilkd. 1988 Aug;193(2):169-73. doi: 10.1055/s-2008-1050240.
9
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.眼眶钴照射联合全身用皮质类固醇治疗格雷夫斯眼病:与单纯全身用皮质类固醇的比较
J Clin Endocrinol Metab. 1983 Jun;56(6):1139-44. doi: 10.1210/jcem-56-6-1139.
10
Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.使用T1映射对格雷夫斯眼病的眼外肌进行定量评估。
Eur Radiol. 2023 Dec;33(12):9074-9083. doi: 10.1007/s00330-023-09931-3. Epub 2023 Jul 19.

引用本文的文献

1
Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy.磁共振成像在甲状腺相关性眼病中的应用进展
Front Endocrinol (Lausanne). 2025 Jun 26;16:1537957. doi: 10.3389/fendo.2025.1537957. eCollection 2025.
2
Predictive markers for anti-inflammatory treatment response in thyroid eye disease.甲状腺眼病抗炎治疗反应的预测标志物。
Front Endocrinol (Lausanne). 2023 Dec 4;14:1292519. doi: 10.3389/fendo.2023.1292519. eCollection 2023.
3
Current insights of applying MRI in Graves' ophthalmopathy.
MRI 在格雷夫斯眼病中的应用研究进展。
Front Endocrinol (Lausanne). 2022 Sep 29;13:991588. doi: 10.3389/fendo.2022.991588. eCollection 2022.
4
Extraocular muscle enlargement.眼外肌肿大。
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3419-3435. doi: 10.1007/s00417-022-05727-1. Epub 2022 Jun 17.
5
Clinical and Radiological Findings in Patients with Newly Diagnosed Graves' Ophthalmopathy.初诊格雷夫斯眼病患者的临床及影像学表现
Int J Endocrinol. 2021 Apr 30;2021:5513008. doi: 10.1155/2021/5513008. eCollection 2021.
6
Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.三维眼眶磁共振T2成像在格雷夫斯眼病患者评估中的应用
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):938-942. doi: 10.1007/s11596-017-1831-8. Epub 2017 Dec 21.
7
Extra-ocular muscle MRI in genetically-defined mitochondrial disease.基因明确的线粒体疾病的眼外肌磁共振成像
Eur Radiol. 2016 Jan;26(1):130-7. doi: 10.1007/s00330-015-3801-5. Epub 2015 May 21.
8
Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment.泼尼松治疗前后格雷夫斯眼病中短时反转恢复序列的诊断准确性
Neuroradiology. 2014 May;56(5):353-61. doi: 10.1007/s00234-014-1332-4. Epub 2014 Feb 27.
9
Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.格雷夫斯眼病的疾病活动度:眼眶磁共振成像诊断及其与临床评分的相关性
Neuroradiol J. 2013 Oct;26(5):555-64. doi: 10.1177/197140091302600509. Epub 2013 Nov 7.
10
Update on advanced imaging options for thyroid-associated orbitopathy.甲状腺相关性眼病的高级成像选项最新进展
Saudi J Ophthalmol. 2012 Oct;26(4):385-92. doi: 10.1016/j.sjopt.2012.07.006.